期刊文献+

槲皮素和山柰酚逆转白血病细胞系K562/A02多药耐药性的机制及相关基因表达谱的研究 被引量:4

Study on Mechamism of Reversing Multidrug Resistance by Quercetin and Keampferol and Their Effects on the Expression of Related Genes in Human Erythroleukemic K562/A02 Cells
原文传递
导出
摘要 目的研究槲皮素(quercetin,Que)及山柰酚(kaempferol,Kae)单用及联合应用时对K562/A02细胞系多药耐药的影响及机制。方法体外培养K562和K562/A02细胞经Que及Kae处理,采用噻唑蓝(MTT)法计算药物单独及联合作用后细胞的生长抑制率及对多柔比星(adriamycin,ADM)的增敏倍数;流式细胞术检测药物作用后细胞内ADM浓度的变化;Annexin V/PI法观察细胞凋亡情况;Real-time PCR基因芯片检测药物转运蛋白及凋亡相关基因表达的变化。结果药物作用48 h后,Que及Kae在5~160μmol.L-1时对K562和K562/A02细胞均有剂量依赖性的生长抑制作用,K562/A02对ADM的敏感性显著增强,二者联用效果有协同性;在ADM为5μmol.L-1时,药物与细胞共培养2 h即可检出Que能增加细胞内ADM的浓度,而Kae则对ADM浓度无明显影响,两药联合作用的效果不及Que单独作用。Que和Kae均可剂量依赖性地诱导K562和K562/A02细胞的凋亡。二者可影响ABC、SLC家族等药物转运蛋白相关基因的表达,并可调节Bcl-2、TNF等凋亡相关基因的表达。结论 Que和Kae可通过多种途径逆转K562/A02的多药耐药性,但二者的作用机制可能不完全相同。 OBJECTIVE To investigate the possibility and mechanism of quercetin and kaempferol, ilavonoid molecules, for reversing multidrug resistance (MDR) in K562/A02 cells. METHODS 562 and K562/A02 cells were cultured in vitro with the flavonoids as single and in combination respectively. Cell growth inhibition and adriamycin (ADM) sensitivity were detected by MTY assay. Intracellular ADM concentration was determined by flow eytometry when K562/A02 cells was cultured with ADM and the flavonoids for 2 h, Cell apoptosis was examined by Annexin V/PI staining method. Moreover, the expression of related genes for drug . transporters and apoptosis was also tested by real time PCR array. RESULTS The MTT assay showed that quercetin and keampferol inhibited the proliferation of K562 and K562/A02 at the concentrnation of 5 -160 mol . L-1. They also increased the sensitivity of K562/A02 cells to ADM at a low toxicity concentration. Flow cytometry showed quercetin increased intracellular ADM in a dose dependent manner, but keampferol showed trivial effect on intracellular ADM accumulation. However, quercetin + keampferol treatment showed a similar effect to that of quercetin alone. Cell apoptosis experiment showed both compounds had a dose dependent effect on I(562 and K562/A02 cells. Furthermore, PCR array showed that some of the genes related to drug transporters such as ATP-binding cassette(ABC) and solute carrier(SLC) and some of the genes related to apoptosis such as Bcl-2, TNF and TNFR families were regulated. CONCLUSION The experiment indicated that quercetin and kaempferol may be used as reveratrol in leukemia chemotherapy, but their interaction and difference should be noticed.
出处 《中国药学杂志》 CAS CSCD 北大核心 2011年第11期830-836,共7页 Chinese Pharmaceutical Journal
基金 内蒙古自然科学基金资助项目(200711020917) 教育部春晖计划科研合作项目(Z2007-1-01006)
关键词 槲皮素 山柰酚 K562/A02 多药耐药性 凋亡 quercetin kempferol K562/A02 Muhidrug resistance apoptosis
  • 相关文献

参考文献24

  • 1KANDASWAMI C, LEE L T, LEE P P, et al. The antitumor activities of flavonoids [ J ]. In Vivo, 2005,19 ( 5 ) : 895-909.
  • 2MERTENS-TALOCTT S U, PERCIVAL S S. Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells[J]. Cancer Lett, 2005, 218(2): 141-151.
  • 3LIMTRA-KUL P, SIWANON S, YODKEEREE S, Effect of Stemona eurtisii root extract on P-glycoprotein and MRP-1 function in multidrug-resistant cancer cells[ J]. Phywmidicine, 2007,14 (6) :381-389.
  • 4MARILYN E, MORRIS, ZHANG S Z. Flavonoid drug interactions: Effects of flavonoids on ABC transporters [ J ]. Life Sci, 2006, 78(18) :2116-2130.
  • 5MARKS D C, BELOV L, DAVEY M W, et al. The MTT cell viability assay for cytotoxicity testing in multidrug resitance human leukemic cells[J]. Leukemia Res, 1992, 16(12) :1165-1173.
  • 6HUANG Y, SADEE W. Membrane transporters and channels in chemoresistance and -sensitivity of tumor ceils [ J ]. Cancer Lett, 2006, 239(2) :168-182.
  • 7CHAN J, DONALSON L M, KUSHWAHA R S, et al. Differential expression of hepatic genes involved in cholesterol homeostasis in high and low-responding strains of laboratory opossums [ J ]. Metabolism, 2008, 57 (5) :718-724.
  • 8HANG Y. Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy [J]. Cancer Metastasis Rev, 2007, 26 (1) :183-201.
  • 9YEE S W, SHIMA J E, HESSELSON S, et al. Identification and characterization of proximal promoter polymorphisms in the human concentrative nucleoside transporter 2 ( SLC28A2 ) [J]. Pharmacol Exp Ther, 2009, 328 ( 3 ) :699-707.
  • 10ZHAO F Q, KEATING A F. Functional properties and genomics of glucose transporters [ J ]. Curr Genomics, 2007, 8 ( 2 ) : 113- 128.

同被引文献35

引证文献4

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部